BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hong S, Song KB, Hwang DW, Lee JH, Lee W, Jun E, Kwon J, Park Y, Park SY, Kim N, Shin D, Kim H, Sung M, Ryu Y, Kim SC. Preoperative serum carbohydrate antigen 19-9 levels predict early recurrence after the resection of early-stage pancreatic ductal adenocarcinoma. World J Gastrointest Surg 2021; 13(11): 1423-1435 [PMID: 34950431 DOI: 10.4240/wjgs.v13.i11.1423]
URL: https://www.wjgnet.com/1948-5204/full/v13/i11/1423.htm
Number Citing Articles
1
Taichi Terai, Minako Nagai, Kota Nakamura, Yuichiro Kohara, Satoshi Yasuda, Yasuko Matsuo, Shunsuke Doi, Takeshi Sakata, Masayuki Sho. Combination of carbohydrate antigen 19-9 level and tumor size after neoadjuvant chemoradiation therapy may predict early recurrence of resectable pancreatic ductal adenocarcinomaPancreatology 2023; 23(8): 970 doi: 10.1016/j.pan.2023.10.014
2
Yuan Zhou, Maoen Pan, Ronggui Lin, Heguang Huang. Advances in hydrogel materials applied to pancreatic-related diseasesJournal of Pancreatology 2024; 7(3): 222 doi: 10.1097/JP9.0000000000000158
3
Zhenshan Shi, Chengle Ma, Xinming Huang, Dairong Cao. Magnetic Resonance Imaging Radiomics‐Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Multicenter StudyJournal of Magnetic Resonance Imaging 2022; 55(3): 823 doi: 10.1002/jmri.28048
4
Jingjing Li, Jiadi Du, Yuying Li, Mingzhu Meng, Junjie Hang, Haifeng Shi. A nomogram based on CT texture features to predict the response of patients with advanced pancreatic cancer treated with chemotherapyBMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02902-4
5
Hang He, Cai-Feng Zou, Yong-Jian Jiang, Feng Yang, Yang Di, Ji Li, Chen Jin, De-Liang Fu. Recurrence scoring system predicting early recurrence for patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy and portomesenteric vein resectionWorld Journal of Gastrointestinal Surgery 2024; 16(10): 3185-3201 doi: 10.4240/wjgs.v16.i10.3185
6
Barbara Wlodarczyk, Lukasz Durko, Przemyslaw Wlodarczyk, Renata Talar-Wojnarowska, Ewa Malecka-Wojciesko. CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) DifferentiationJournal of Clinical Medicine 2023; 12(12): 4050 doi: 10.3390/jcm12124050
7
Hye Yeon Chon, Hee Seung Lee, You-Na Sung, Yoo Keung Tae, Chan Hee Park, Galam Leem, So Jung Kim, Jung Hyun Jo, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Seung-Mo Hong, Seungmin Bang. Uncovering the clinicopathological features of early recurrence after surgical resection of pancreatic cancerScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-52909-4
8
Edin Hodžić, Sadat Pušina, Adi Mulabdić, Mirhan Salibašić, Emsad Halilović, Mujo Kadrić. Prognostic relevance of preoperative CA 19-9 values in stage III rectal adenocarcinoma: retrospective analysis and clinical implicationsMedicinski Glasnik 2024; 21(2): 362 doi: 10.17392/1701-21-02
9
Hang He, Cai-Feng Zou, Feng Yang, Yang Di, Chen Jin, De-Liang Fu. Postoperative serum tumor markers-based nomogram predicting early recurrence for patients undergoing radical resections of pancreatic ductal adenocarcinomaWorld Journal of Gastrointestinal Surgery 2024; 16(10): 3211-3223 doi: 10.4240/wjgs.v16.i10.3211